These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 12648336)

  • 1. Femoro-femoral arterial bypass is an effective and durable treatment for symptomatic unilateral iliac artery occlusion.
    Pai M; Handa A; Hands L; Collin J
    Ann R Coll Surg Engl; 2003 Mar; 85(2):88-90. PubMed ID: 12648336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Factors determining late patency of aortobifemoral bypass graft].
    Davidović LB; Lotina SI; Kostić DM; Cinara II; Cvetković SD; Stojanov PL; Velimirović DB; Marković MM; Pejkić SA; Vukotić AM
    Srp Arh Celok Lek; 1997; 125(1-2):24-35. PubMed ID: 17974352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term results of a multicenter randomized study on direct versus crossover bypass for unilateral iliac artery occlusive disease.
    Ricco JB; Probst H;
    J Vasc Surg; 2008 Jan; 47(1):45-53; discussion 53-4. PubMed ID: 17997269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Extra-anatomy axillary-femoral or femoro-femoral bypass grafting for the treatment of aorta-iliac occlusive disease].
    Ye J; Wang Y; Fan L; Chen F; Fu W
    Zhonghua Wai Ke Za Zhi; 1998 Aug; 36(8):457-8. PubMed ID: 11825437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of unilateral iliac artery disease by femorofemoral bypass grafting.
    Sheiner NM; Ashby D; Zeltzer J
    Can J Surg; 1979 Sep; 22(5):474-6. PubMed ID: 159115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Femorofemoral bypass graft: analysis of patency and factors influencing long-term outcome.
    Criado E; Burnham SJ; Tinsley EA; Johnson G; Keagy BA
    J Vasc Surg; 1993 Sep; 18(3):495-504; discussion 504-5. PubMed ID: 8377244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Surgery of abdominal aorta with horseshoe kidney].
    Lotina SL; Davidović LB; Kostić DM; Velimirović DV; Petrović PLj; Perisić-Savić MV; KovacevićN S
    Srp Arh Celok Lek; 1997; 125(1-2):36-44. PubMed ID: 17974353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of aortofemoral bypass in the management of unilateral iliac occlusive disease. A follow-up study of 95 patients over a 25-year period].
    Taurino M; Maggiore C; Ricci B; Rizzo L; Maraglino C; Speziale F; Fiorani P
    Minerva Cardioangiol; 2002 Apr; 50(2):133-41. PubMed ID: 12032467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term results of above knee femoro-popliteal bypass depend on indication for surgery and graft-material.
    Berglund J; Björck M; Elfström J;
    Eur J Vasc Endovasc Surg; 2005 Apr; 29(4):412-8. PubMed ID: 15776397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Femorofemoral bypass: a profile of graft failure.
    Farber MA; Hollier LH; Eubanks R; Ochsner JL; Bowen JC
    South Med J; 1990 Dec; 83(12):1437-43. PubMed ID: 2251532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is femorofemoral crossover bypass an option in claudication?
    Capoccia L; Riambau V; da Rocha M
    Ann Vasc Surg; 2010 Aug; 24(6):828-32. PubMed ID: 20638622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Popliteal artery aneurysms. Factors associated with thromboembolism and graft failure.
    Martelli E; Ippoliti A; Ventoruzzo G; De Vivo G; Ascoli Marchetti A; Pistolese GR
    Int Angiol; 2004 Mar; 23(1):54-65. PubMed ID: 15156131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iliac occlusions: stenting or crossover grafting? An examination of patency and cost.
    Whatling PJ; Gibson M; Torrie EP; Magee TR; Galland RB
    Eur J Vasc Endovasc Surg; 2000 Jul; 20(1):36-40. PubMed ID: 10906295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The distaflo graft: a valid alternative to interposition vein?
    Fisher RK; Kirkpatrick UJ; How TV; Brennan JA; Gilling-Smith GL; Harris PL
    Eur J Vasc Endovasc Surg; 2003 Mar; 25(3):235-9. PubMed ID: 12623335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors affecting the long-term patency of crossover femorofemoral bypass graft.
    Kim YW; Lee JH; Kim HG; Huh S
    Eur J Vasc Endovasc Surg; 2005 Oct; 30(4):376-80. PubMed ID: 15890541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of profunda femoris revascularization in aortofemoral surgery. An analysis of factors affecting graft patency.
    Bastounis E; Felekouras E; Pikoulis E; Hadjinikolaou L; Georgopoulos S; Balas P
    Int Angiol; 1997 Jun; 16(2):107-13. PubMed ID: 9257671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Management of arterial occlusive diseases of abdominal aorta and iliac artery: experience with 267 cases].
    Wu Q; Chen Z; Tang X
    Zhonghua Wai Ke Za Zhi; 2001 Nov; 39(11):832-4. PubMed ID: 11930733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of donor limb hemodynamics in femorofemoral bypass for claudication.
    Harris JP; Flinn WR; Rudo ND; Bergan JJ; Yao JS
    Surgery; 1981 Oct; 90(4):764-73. PubMed ID: 6456562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative evaluation of femorofemoral crossover bypass and iliofemoral bypass for unilateral iliac artery occlusive disease.
    Nazzal MM; Hoballah JJ; Jacobovicz C; Mohan CR; Martinasevic M; Ryan SM; Sharp WJ; Kresowik TF; Corson JD
    Angiology; 1998 Apr; 49(4):259-65. PubMed ID: 9555928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Femoro-femoral graft after unilateral obstruction of aorto-bifemoral bypass.
    Testini M; Todisco C; Greco L; Impedovo G; Fullone M; Regina G
    Minerva Cardioangiol; 1998; 46(1-2):15-9. PubMed ID: 9780617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.